SSPC, Taighde Éireann – Research Ireland Centre for PharmaceuticalsDiscover Our Impacts - Faigh amach faoinár dtionchair
SSPC provides the life sciences sector with a nationally distributed, research performing community that enables high impact, collaborative research between industry and academic partners.
SSPC is committed to translating its excellent science into impact through five societal goals: Sustainability, Small Molecule, Biologics, Health, Education and Public Engagement.
Sustainability
Small Molecule
Biologics
Health
Education & Public Engagement
Talent
SSPC nurtures a talent pipeline of high calibre scientists and engineers for the sector, through our internal PhD training programme and various CPD mechanisms available to our industry partners. SSPC offers a unique proposition through its industry placement programme and 63% of SSPC graduates go on to be employed in industry both nationally and globally.
Industry
Since its inception, SSPC has successfully collaborated with over 50 industry partners, composed of indigenous and foreign operations, whose size range from small to multi-national. Collectively, this demonstrates a strong track-record in delivering applied research that enables industry to solve challenges leading to the development of better medicine. SSPC has supported 54 industry projects since 2019.
Researchers
Economic Impact since 2013
Industry Partners
Jobs created in industry following FDI
Peer-Reviewed Publications
International Co-Authors in 48 countries across 6 continents
%
Transition of Researchers to Industry
Education & Public Engagement Activities
Latest News
All you need to know about painkillers
Ireland has a strong presence in this developing space. Research into novel and improved forms of painkiller is a hot topic within the scientific community. Researchers in SSPC, hosted by the Bernal Institute in the University of Limerick, are...
Irish Government launch new Covid-19 tracker app
The Department of Health and the Health Service Executive launched the app to help identify close contacts of people who test positive for the disease. Acting Chief Medical Officer Dr Ronan Glynn said: "This is one more example of the solidarity and...
M-Star CFD joins SSPC
SSPC and M-Star CFD, have joined together in a strategic partnership agreement that promotes a strong alliance in order to ensure SSPC’s customers can access high-level software needed for new research endeavours. This move represents an ongoing commitment by SSPC to...
SSPC Years in Review, and News Updates
View or download our latest news and research outputs.
SSPC’s world-leading Research Programme
Our unique and innovative culture of collaboration is helping the global pharmaceutical and biopharmaceutical industry to develop more environmentally sustainable methods for drug manufacturing; to increase the range of medicines available to the public and to reduce drug manufacturing costs. SSPC’s advanced research programme extends from Molecule, Materials and Medicine into the Manufacturing and Modelling space.
These themes focus on developing new methodologies for the asymmetric synthesis of APIs, molecules & methods for automated & in-flow generation of targeted drug hybrids & new therapeutic agents.
Advancing the understanding of single-component crystalline materials (SCCMs) and, especially, multi-component crystalline materials (MCCMs) in order to enable improved orally delivered drug products.
Optimising the development, production & use of safe, effective medicines with focus on poorly soluble drugs, personalized, age appropriate medicines & rational formulation approaches with predictive performance.
Enabling a disruptive change in manufacture of drug substances & drug products, through the development & implementation of continuous manufacturing, flow chemistry & end-to-end manufacturing methodologies.
























